TL-532

N/A

Report date: 2023/11/06 13:33:31

NME

Base Information

Drug NameTL-532

Drug Alias NameTL-532

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionToll like receptor 3 agonists

TargetsToll like receptor 3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTollys Sas

China Registration ClassN/A

Active CompaniesTollys Sas

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A